Latvia's largest pharmaceutical company, Grindex, saw a record profit of 4.5 million lats (6.4 million euros) in 2005 - 81 percent more than the year before. The firm's net turnover grew 30.3 percent last year, reaching 32.2 million lats, according to the financial report the company submitted to the Riga Stock Exchange. "Total turnover growth has been achieved mostly due to the ever-increasing sales of ready-made medicines," Grindex management said in its report.Grindex board chairman Valdis Jakobsons said the company continued to develop its network in existing markets, while expanding o...
The article you requested can be accessed only by subscribing to the online version of The Baltic Times. If you are already subscribed to The Baltic Times, please authorize yourself.
In case you don't have a subscription yet - please visit our SUBSCRIPTION